These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 3925768
21. Has the time come for cost-effectiveness analysis in US health care? Bryan S, Sofaer S, Siegelberg T, Gold M. Health Econ Policy Law; 2009 Oct; 4(Pt 4):425-43. PubMed ID: 19203399 [Abstract] [Full Text] [Related]
22. A cost-benefit analysis of preventive schistosomiasis interventions in Kenya. Kirigia JM, Sambo LG, Kainyu LH. Afr J Health Sci; 2000 Oct; 7(3-4):5-11. PubMed ID: 17650020 [Abstract] [Full Text] [Related]
23. [What is cost effectiveness analysis?]. Alban A, Danneskiold-Samsøe B, Pedersen KM. Ugeskr Laeger; 1990 Jan 08; 152(2):81-6. PubMed ID: 2105549 [Abstract] [Full Text] [Related]
26. Calculating costs of drug therapy: a review of a decade of literature (1977-1987). Simpson CA, Souney PF. Clin Ther; 1988 11 27; 10(6):616-50. PubMed ID: 3064904 [Abstract] [Full Text] [Related]
27. Using cost-effectiveness analysis in policy formulation in human service organizations. Holosko MJ, Dobrowolsky J, Feit MD. J Health Soc Policy; 1989 11 27; 1(1):43-60. PubMed ID: 10313498 [Abstract] [Full Text] [Related]
28. Valuing the Clinical Effectiveness of Therapeutics. Listl S, Faggion CM. J Evid Based Dent Pract; 2016 Jun 27; 16(2):86-9. PubMed ID: 27449834 [Abstract] [Full Text] [Related]
29. Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare. Brent RJ. Int J Environ Res Public Health; 2023 Mar 06; 20(5):. PubMed ID: 36901658 [Abstract] [Full Text] [Related]
30. Sounding Boards. What is CBA/CEA, and why are they doing this to us? Fuchs VR. N Engl J Med; 1980 Oct 16; 303(16):937-8. PubMed ID: 6774250 [No Abstract] [Full Text] [Related]
31. Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis? Culyer AJ, Chalkidou K. Value Health; 2019 Jan 16; 22(1):99-103. PubMed ID: 30661640 [Abstract] [Full Text] [Related]
32. Assessing the cost-effectiveness of prevention. Banta HD, Luce BR. J Community Health; 1983 Jan 16; 9(2):145-65. PubMed ID: 6430973 [Abstract] [Full Text] [Related]
33. Cost-benefit analysis of passive fire protections in road LPG transportation. Paltrinieri N, Bonvicini S, Spadoni G, Cozzani V. Risk Anal; 2012 Feb 16; 32(2):200-19; discussion 220-3. PubMed ID: 21762459 [Abstract] [Full Text] [Related]
34. Economic evaluation of pharmacologic therapy. Hill WL. Drug Intell Clin Pharm; 1986 Feb 16; 20(7-8):594-6. PubMed ID: 3091348 [Abstract] [Full Text] [Related]
36. The pursuit of transparency and quality improvement in cost-effectiveness analysis - a case study in disease-modifying drugs for the treatment of multiple sclerosis. Bell CF. J Manag Care Pharm; 2011 Nov 16; 17(6):463-8. PubMed ID: 21787032 [Abstract] [Full Text] [Related]
37. Application of cost-benefit and cost-effectiveness analysis to clinical practice. Bootman JL, McGhan WF, Schondelmeyer SW. Drug Intell Clin Pharm; 1982 Mar 16; 16(3):235-43. PubMed ID: 6800752 [Abstract] [Full Text] [Related]
38. What is cost-effectiveness analysis? Evans DB. Med J Aust; 1990 Aug 06; 153(S1):S7-9. PubMed ID: 2116585 [Abstract] [Full Text] [Related]
39. The once and future application of cost-effectiveness analysis. Berger ML. Jt Comm J Qual Improv; 1999 Sep 06; 25(9):455-61. PubMed ID: 10481814 [Abstract] [Full Text] [Related]
40. Issues in cost effectiveness in health care. Warner KE. J Public Health Dent; 1989 Sep 06; 49(5 Spec No):272-8. PubMed ID: 2509690 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]